Growth in this market is mainly driven by technological advancements, increasing demand for self-injection devices, and the rising incidence of chronic diseases.
[238 Pages Report] The needle-free injection system market is projected to reach USD 272 million by 2026 from USD 124 million in 2021, at a CAGR of 17.0% from 2021 to 2026.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861
Report Scope and Market Segmentation:
Report Metric Details
Market Size Available for Years 2019–2026
Base Year Considered 2020
Forecast Period 2022–2026
Forecast Units Value (USD Billion)
Segments Covered By Product Type, Application, products, Technology, Site of delivery, End User and Region
Geographies Covered North America, Europe, APAC, Latin America and Middle East & Africa
Companies Covered PharmaJet (US), Portal Instruments (US), Medical International Technology, Inc (MIT) (US), NuGen Medical Devices (Canada), Crossject SA (US), Bioject Medical Technologies (US) among others.

Fillable segment accounted for the largest share in the needle-free injection system market.
Based on applications, the needle-free injection system market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and other applications. vaccine delivery is estimated to account for the largest share of 32.8% of the needle-free injection system market by application.
liquid-based injectors segment accounted for the largest share in the needle-free injection system market.
Based on the type, the needle-free injection system market is segmented into liquid-based, powder-based and projectile/depot-based needle-free injectors. The liquid-based segment accounted for the largest share of 70.9% of the needle-free injection system market
North America accounted segment accounted for the largest share in the needle-free injection system market.
On the basis of region, the needle-free injection system market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 58% of the needle-free injection market, followed by Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. However, the APAC region is expected to grow at the highest CAGR of 18.7% during the forecast period.
PHARMAJET
PharmaJet held the first position in the needle-free injection system market in 2020. PharmaJet is a leading provider of needle-free injectors. The company has developed PharmaJet Needle-free devices that deliver pharmaceuticals, vaccines, and liquid injectables through the skin, accomplished by the use of jet injection technology.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861